Results 121 to 130 of about 7,679 (193)

Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study. [PDF]

J Asthma Allergy
Lukka PB, Penland RC, Brekkan A, Ayoun Alsoud R, So S, Boulton DW.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective. [PDF]

PLoS One
Shi C, Wang Y, Tan C, Zeng X, Liu Q.
europepmc   +1 more source

Biologic switching in allergic bronchopulmonary aspergillosis: a scoping review of published clinical experience. [PDF]

J Thorac Dis
Hu Q, Pan X, Chen R, Li G, Li Y, Zheng Y, Zhong Z, Zhang X, Chen Y, Ye J, Duan J, Li J.   +11 more
europepmc   +1 more source

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. [PDF]

Eur Respir J
Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Smith JA, O'Byrne PM, Satia I, Gauvreau GM.   +17 more
europepmc   +1 more source

Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review. [PDF]

Hum Vaccin Immunother
Park MJ, Han JK, Lam KK.
europepmc   +1 more source

Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) with Mepolizumab or Dupilumab: A Preliminary Single-Center Study for Evaluation of Safety and Efficacy. [PDF]

J Pers Med
Bertolini M, Fucci L, Guastini L, Conti C, Santori G, Canevari FRM.   +5 more
europepmc   +1 more source

Steroid-Free Remission of Eosinophilic Granulomatosis With Polyangiitis Achieved With Low-Dose Mepolizumab: A Case Report. [PDF]

Clin Case Rep
Matsuoka S, Takigawa Y, Nishimura J, Watanabe H, Kudo K, Sato K, Fujiwara K, Shibayama T.   +7 more
europepmc   +1 more source

Age-specific efficacy of biologics in severe asthma: a pediatric perspective. [PDF]

Front Allergy
Andrenacci B, Calciano F, Madini B, Rocchi A, Ghiglioni DG, Maffeis L, Patria MF, Licari A, Marseglia GL.   +8 more
europepmc   +1 more source

Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma. [PDF]

J Allergy Clin Immunol Glob
Matsuno O, Kawashima K, Hanada Y, Wibowo T, Ishida Y, Ogata A.   +5 more
europepmc   +1 more source

Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HES. [PDF]

J Allergy Clin Immunol Glob
Wechsler ME, Kovalszki A, Stone B, Silver J, Seluk L, Hwee J, Huynh L, da Costa Junior W, Wang S, Duh MS, McCann W, Edgecomb AG.   +11 more
europepmc   +1 more source